Victor Ling, O.C., O.B.C., Ph.D.
President & Scientific Director
Terry Fox Research Institute

Victor Ling is President and Scientific Director of the Canada-wide Terry Fox Research Institute (www.tfri.ca). He is a distinguished scientist at the BC Cancer Agency (BCCA) and Professor of Pathology and Laboratory Medicine at the University of British Columbia (UBC). He is also Director of the Interdisciplinary Oncology graduate training program (www.iop.ca), a partnership between BCCA and UBC.

Previously he was Vice-president of Research at the BC Cancer Agency and Assistant Dean at UBC. He has served on a number of boards including: Governing Council of CIHR, Board of NCI Canada, Medical Advisory Committee of the Gairdner Foundation, Board of Scientific Counselors at NCI/NIH, and Scientific Advisory Committee of the Alberta Heritage Foundation for Medical Research. He also chairs the Governance and Oversight Committee of CTRNet.

Dr. Ling is best known for his discovery of P-glycoprotein (MDR), a major mechanism of resistance to anticancer drugs. He has been honoured by the General Motors Kettering Prize, the Dr. Josef Steiner Cancer Research Award, the Gairdner Foundation International Award, a Michael Smith Foundation Distinguished Scholar Award and many others. He has received honorary degrees from four different Canadian universities, the Order of British Columbia, the Order of Canada and is a fellow of the Royal Society of Canada.